GRIN3A and brain infarction: In summary, MCAO rats on Simvastatin pretreatment could markedly improve the neurological deficit, reduce brain infarct area, enhance the expression levels of PP2A and NR3A, and decrease the protein levels of phosphorylation of NR1 (ser896, ser897).